No impact of seronegativity on the efficacy of a biosimilar rituximab in biologic-naïve patients with active rheumatoid arthritis
Saved in:
Main Authors: | Nedumooli Pottammal Jamshid, Vinod Ravindran |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-01-01
|
Series: | Indian Journal of Rheumatology |
Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2019;volume=14;issue=1;spage=77;epage=78;aulast=Jamshid |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unilateral RS3PE in a Patient of Seronegative Rheumatoid Arthritis
by: Ankur Nandan Varshney, et al.
Published: (2013-01-01) -
Expert Panel consensus statements on the optimal usage of rituximab for the management of rheumatoid arthritis in India
by: Keerthi Talari, et al.
Published: (2021-01-01) -
A Case of Multiple Myeloma Misdiagnosed as Seronegative Rheumatoid Arthritis and Review of Relevant Literature
by: Scott Schoninger, et al.
Published: (2018-01-01) -
Seronegative Arthritis and Whipple Disease: Risk of Misdiagnosis in the Era of Biologic Agents
by: Luca Quartuccio, et al.
Published: (2019-01-01) -
Risk Evaluation for the Formation of Gastroduodenal Erosion and Ulceration Induced by Meloxicam in Patients with Seropositive and Seronegative Rheumatoid Arthritis
by: R. A. Pavlyukov, et al.
Published: (2019-05-01)